These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24931843)
1. Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions. Tsantes AE; Kyriakou E; Nikolopoulos GK; Stylos D; Sidhom M; Bonovas S; Douramani P; Kalantzis D; Kokoris S; Valsami S; Stamoulis K; Politou M; Foudoulaki-Paparizos L Blood Transfus; 2014 Apr; 12(2):232-7. PubMed ID: 24931843 [TBL] [Abstract][Full Text] [Related]
2. Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012. Menis M; Forshee RA; Anderson SA; McKean S; Gondalia R; Warnock R; Johnson C; Mintz PD; Worrall CM; Kelman JA; Izurieta HS Vox Sang; 2015 Apr; 108(3):251-61. PubMed ID: 25470076 [TBL] [Abstract][Full Text] [Related]
3. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients. Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127 [TBL] [Abstract][Full Text] [Related]
4. Changes in circulating inflammatory markers following febrile non-haemolytic transfusion reactions to leucoreduced red cells. Larsen R; Sandhu N; Heegaard NHH; Ullum H; von Stemann JH; Sørensen E; Nellemann DS; Hansen MB Vox Sang; 2018 Jan; 113(1):76-79. PubMed ID: 29023768 [TBL] [Abstract][Full Text] [Related]
5. Clinical effects of leucoreduction of blood transfusions. Bilgin YM; van de Watering LM; Brand A Neth J Med; 2011 Oct; 69(10):441-50. PubMed ID: 22058263 [TBL] [Abstract][Full Text] [Related]
6. Blood donation and blood transfusion in Spain (1997 - 2007): the effects of demographic changes and universal leucoreduction. García-Erce JA; Campos A; Muñoz M Blood Transfus; 2010 Apr; 8(2):100-6. PubMed ID: 20383303 [TBL] [Abstract][Full Text] [Related]
7. A randomized control trial to compare mortality in recipients of leucoreduced and non-leucoreduced whole blood transfusion in patients with cancer in Uganda. Okello CD; Orem J; Nabwana M; Kiwanuka N; Shih AW; Heddle N; Mayanja-Kizza H BMC Cancer; 2024 Jun; 24(1):677. PubMed ID: 38831291 [TBL] [Abstract][Full Text] [Related]
8. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962 [TBL] [Abstract][Full Text] [Related]
9. Laboratory and clinical comparison of the efficacy of prestorage leukoreduction of red cells at cold versus room temperature. Mittal S; Chacko MP; Varughese S; Raj A; Gowri M; Thankachen R; Mammen J; Daniel D Transfusion; 2021 Sep; 61(9):2556-2565. PubMed ID: 34169541 [TBL] [Abstract][Full Text] [Related]
10. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730 [TBL] [Abstract][Full Text] [Related]
11. Research progress on febrile non-hemolytic transfusion reaction: a narrative review. Wang H; Ren D; Sun H; Liu J Ann Transl Med; 2022 Dec; 10(24):1401. PubMed ID: 36660666 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery. van Hulst M; Bilgin YM; van de Watering LM; de Vries R; van Oers MH; Brand A; Postma MJ Transfus Med; 2005 Jun; 15(3):209-17. PubMed ID: 15943705 [TBL] [Abstract][Full Text] [Related]
14. The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration. Silliman CC; Burke T; Kelher MR Blood Transfus; 2017 Mar; 15(2):131-136. PubMed ID: 28263170 [TBL] [Abstract][Full Text] [Related]
15. Human platelet antigens are associated with febrile non-hemolytic transfusion reactions. Chen DP; Wen YH; Lu JJ; Tseng CP; Chen WL; Chang SW Clin Chim Acta; 2017 Nov; 474():120-123. PubMed ID: 28919492 [TBL] [Abstract][Full Text] [Related]
16. Febrile transfusion reaction: what blood component should be given next? Menitove JE; McElligott MC; Aster RH Vox Sang; 1982; 42(6):318-21. PubMed ID: 7113112 [TBL] [Abstract][Full Text] [Related]
17. Improved leucoreduction of red blood cell units prepared after a 24-h hold with the platelet-rich plasma method using newly developed filters. Thibault L; Beauséjour A; Jacques A; de Grandmont MJ; Lemieux R; Grégoire Y; Ducas E; Boucher G Vox Sang; 2008 May; 94(4):286-91. PubMed ID: 18208406 [TBL] [Abstract][Full Text] [Related]
18. Analysis of Clinical Factors Associated with the Occurrence Time of AllergicTransfusion Reactions or Febrile Non-HemolyticTransfusion Reactions. Yanagisawa R; Yamanaka R; Shimodaira S Ann Clin Lab Sci; 2022 May; 52(3):382-390. PubMed ID: 35777807 [TBL] [Abstract][Full Text] [Related]
19. The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm. Bennardello F; Fidone C; Spadola V; Cabibbo S; Travali S; Garozzo G; Antolino A; Tavolino G; Falla C; Bonomo P Blood Transfus; 2013 Jul; 11(3):377-84. PubMed ID: 23736930 [TBL] [Abstract][Full Text] [Related]
20. [Relevance of safety measures to avoid HTLV transmission by transfusion in 2014]. Laperche S; Pillonel J Transfus Clin Biol; 2014 Nov; 21(4-5):167-72. PubMed ID: 25267203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]